VA Medicinal Cannabis Research Act of 2019

11/1/2022, 2:32 PM

Congressional Summary of HR 712

VA Medicinal Cannabis Research Act of 2019

This bill requires the Department of Veterans Affairs (VA) to conduct a clinical trial of the effects of medical-grade cannabis on the health outcomes of covered veterans diagnosed with chronic pain, and also those diagnosed with post-traumatic stress disorder. Covered veterans are those who are enrolled in the VA patient enrollment system for hospital care and medical services.

Current Status of Bill HR 712

Bill HR 712 is currently in the status of Bill Introduced since January 23, 2019. Bill HR 712 was introduced during Congress 116 and was introduced to the House on January 23, 2019.  Bill HR 712's most recent activity was Ordered to be Reported (Amended) by Voice Vote. as of March 12, 2020

Bipartisan Support of Bill HR 712

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
105
Democrat Cosponsors
96
Republican Cosponsors
9
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 712

Primary Policy Focus

Armed Forces and National Security

Potential Impact Areas

Alternative treatmentsCongressional oversightDrug trafficking and controlled substancesGovernment studies and investigationsHealth information and medical recordsMedical researchMental healthNeurological disordersVeterans' medical care

Alternate Title(s) of Bill HR 712

VA Medicinal Cannabis Research Act of 2019To direct the Secretary of Veterans Affairs to carry out a clinical trial of the effects of cannabis on certain health outcomes of adults with chronic pain and post-traumatic stress disorder, and for other purposes.VA Medicinal Cannabis Research Act of 2019
Start holding our government accountable!

Comments